2318
J. RESTREPO ET AL.
7-Chloro-3-(4-methylphenyl)-4H-1,2,4-benzothiadiazine-1,1-dioxide (2c): Beige
solid, mp 335 ◦C–337 ◦C. 1H NMR: δ 11.68 (s, 1H, NH), 7.77 (d, 2H, ArH, J = 8.1 Hz,
H3ꢀ, H5ꢀ), 7.62 (d, 1H, ArH, J = 2.2 Hz, H8), 7.40 (d, 1H, ArH, J = 8.8 Hz, H6), 7.29
(dd, 1H, ArH, J = 2.2 Hz, J = 8.8 Hz, H5), 7.11 (d, 2H, ArH, J = 8.1 Hz, H2ꢀ, H6ꢀ),
2.22 (s, 3H, CH3); 13C NMR: δ 143.7, 134.5, 132.8, 130.9, 129.3, 128.9, 128.5, 123.3,
120.2, 118.6, 21.5; IR (KBr, cm−1) υ: 3310 (NH), 1360 (SO2), 1156 (SO2); Anal. Calcd.
for C14H11ClN2O2S; C, 54.81; H, 3.61; N, 9.13. Found: C, 54.58; H, 3.74; N, 9.25.
7-Chloro-3-(4-c◦hloroph◦enyl)-4H-1,2,4-benzothiadiazine-1,1-dioxide
(2d):
1
Brown solid, mp 285 C–287 C. H NMR: δ 11.71 (s, 1H, NH), 7.46 (d, 1H, ArH, J =
8.1 Hz, H3ꢀ, H5ꢀ), 7.18 (d, 1H, ArH, J = 2.0 Hz, H8), 7.00 (m, 2H, ArH), 6.95 (d, 2H,
ArH, J = 8.1 Hz, H2ꢀ,6ꢀ); 13C NMR: δ 153.7, 138.5, 134.1, 132.8, 130.7, 129.9, 129.7,
128.6, 122.6, 122.3, 120.3; IR (KBr, cm−1) υ: 3315 (NH), 1360 (SO2), 1158 (SO2); Anal.
Calcd. for C13H8Cl2N2O2S; C, 47.72; H, 2.46; N, 8.56. Found: C, 47.93; H, 2.52; N, 8.45.
7-Chloro-3-(3-fluorophenyl)-4H-1,2,4-benzothiadiazine-1,1-dioxide (2e): Brown
solid, mp 339 ◦C–340 ◦C. 1H NMR: δ 11.76 (s, 1H, NH), 7.64 (m, 3H, ArH), 7.28 (m, 3H,
ArH), 7.08 (m, 1H, ArH); 13C NMR: δ 154.6, 134.2, 133.0, 131.4, 130.5 (d, J = 8.4 Hz),
124.4, 123.5, 122.9, 120.2, 119.9 (d, J = 20.6 Hz), 116.1, 115.5. 19F NMR: δ −111.5; IR
(KBr, cm−1) υ: 3316 (NH), 1368 (SO2), 1167 (SO2); Anal. Calcd. for C13H8ClFN2O2S; C,
50.25; H, 2.60; N, 9.02. Found: C, 50.08; H, 2.73; N, 8.89.
7-Bromo-3-(3-methylphenyl)-4H-1,2,4-benzothiadiazine-1,1-dioxide (2f): Beige
solid, mp 190 ◦C–192 ◦C. 1H NMR: δ 12.29 (s, 1H, NH), 8.01 (d, 1H, ArH, J = 2.0 Hz),
7.93 (dd, 1H, J = 2.0 Hz, J = 8.8 Hz), 7.86 (s, 1H, ArH), 7.60 (d, 1H, ArH, J = 8.8
Hz), 7.51 (d, 2H, ArH, J = 8.8 Hz, H2ꢀ, H6ꢀ), 7.53 (bs, 2H, ArH), 2.44 (s, 3H, CH3).;13C
NMR: δ 155.6, 139.0, 136.6, 135.4, 134.2, 132.2, 129.4, 129.2, 126.1, 125.9, 123.4, 121.6,
118.3, 21.5; IR (KBr, cm−1) υ: 3314 (NH), 1354 (SO2), 1165 (SO2); Anal. Calcd. for
C14H11BrN2O2S; C, 47.88; H, 3.16; N, 7.98. Found: C, 47.99; H, 3.25; N, 7.86.
6,7-Dichloro-3-(2-chlorophenyl)-4H-1,2,4-benzothiadiazine-1,1-dioxide
(2g):
Brown solid, mp 271 ◦C–272 ◦C. 1H NMR: δ 11.84 (s, 1H, NH), 8.29 (s, 1H, ArH), 8.60
(s, 1H, ArH), 8.50 (d, 1H, ArH, J = 8.1 Hz), 8.25 (dd, 1H, ArH, J = 8.1 Hz, J = 7.8 Hz),
7.86 (d, 1H, ArH, J = 8.1 Hz), 7,78 (t, 1H, ArH, J = 7.7 Hz, J = 7.7 Hz); IR (KBr, cm−1
)
υ: 3312 (NH), 1366 (SO2), 1162 (SO2); Anal. Calcd. for C13H7Cl3N2O2S; C, 43.18; H,
1.95; N, 7.75. Found: C, 43.09; H, 1.90; N, 7.71.
General Procedure for the Preparation of 3-Aryl-4H-1,2,4-
Benzothiadiazine-1,1-Dioxides 2a–d and f–g from
2-Aminobenzenesulfonamides and Benzoic Acid (Method B)
A mixture of the corresponding 2-aminobenzenesulfonamide 1a–d (16 mg;
0.062 mmol), appropriate substituted benzoic acid (0.124 mmol), 5% mol of hydrochloric
acid (10N solution), and dimethylacetamide (1 mL) was microwave-irradiated at several
stages (3 min each) to complete the indicated time. An initial microwave-promoted
preheating of 30 s (50% power) was needed in all cases, followed by six irradiation
steps of 3 min each (90% power). The reaction was followed by TLC until the starting
5-bromo-2-aminobenzenesulfonamide was consumed. After being cooled to room
temperature, an amount of ice water was added to the resulting mixture to precipitate the
products that were then filtered and washed three times with cool water and dried in vacuo
to give compounds 2a–d and f–g.